نتائج البحث

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.

• Authors : Linton, A¹; Cheng, Y Y¹; Griggs, K²

• Source: British Journal of Cancer. 1/21/2014, Vol. 110 Issue 2, p510-519. 10p.

تفاصيل العنوان

Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.

• Authors : Goparaju, C M¹; Blasberg, J D²; Volinia, S³

• Source: Oncogene. 6/16/2011, Vol. 30 Issue 24, p2767-2777. 11p. 4 Black and White Photographs, 1 Diagram, 1 Chart, 4 Graphs.

تفاصيل العنوان

Attributable risk in men in two French case-control studies on mesothelioma and asbestos.

• Authors : Lacourt, Aude ; Rolland, Patrick; Gramond, Céline

Subjects: *MESOTHELIOMA risk factors; *ASBESTOS & health; *CASE-control method

• Source: European Journal of Epidemiology. Nov2010, Vol. 25 Issue 11, p799-806. 8p. 4 Charts.

تفاصيل العنوان

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

• Authors : Kirschner, Michaela B; Pulford, Emily; Hoda, Mir Alireza

Subjects: PLEURA cancer; FIBULINS; ENZYME-linked immunosorbent assay

• Source: British Journal of Cancer; 9/15/2015, Vol. 113 Issue 6, p963-969, 7p, 1 Chart, 3 Graphs

تفاصيل العنوان

Evaluation of preventive tract embolization with standardized gelatin sponge slurry on chest tube placement rate after CT-guided lung biopsy: a propensity score analysis.

• Authors : Grange, Rémi¹ (AUTHOR) ; Di Bisceglie, Mathieu² (AUTHOR); Habert, Paul^3,4 (AUTHOR)

• Source: Insights into Imaging. 11/28/2023, Vol. 14 Issue 1, p1-9. 9p.

تفاصيل العنوان

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin.

• Authors : Giovannetti, E; Zucali, P A; Assaraf, Y G

Subjects: MESOTHELIOMA; DRUG synergism; THYMIDYLATE synthase

• Source: British Journal of Cancer; 11/8/2011, Vol. 105 Issue 10, p1542-1553, 12p, 1 Diagram, 3 Charts, 3 Graphs

تفاصيل العنوان

The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.

• Authors : Nutt, J. E.; Razak, A. R. A.; O'Toole, K.

Subjects: DRUG therapy; MESOTHELIOMA; CELL lines

• Source: British Journal of Cancer; 2/10/2010, Vol. 102 Issue 3, p553-560, 8p, 1 Diagram, 2 Charts, 4 Graphs

تفاصيل العنوان

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.

• Authors : Alì, G.; Boldrini, L.; Lucchi, M.

Subjects: INTERLEUKIN-2; IMMUNOMODULATORS; MESOTHELIOMA

• Source: British Journal of Cancer; 12/7/2009, Vol. 101 Issue 11, p1869-1875, 7p, 1 Black and White Photograph, 5 Charts, 1 Graph

تفاصيل العنوان

Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial.

• Authors : Seto, T.; Ushijima, S.; Yamamoto, H.

Subjects: LUNG cancer; CANCER treatment; PLEURAL effusions

• Source: British Journal of Cancer; 9/18/2006, Vol. 95 Issue 6, p717-721, 5p, 2 Charts, 1 Graph

تفاصيل العنوان

Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies.

• Authors : Monneuse, O; Beaujard, A C; Guibert, B

Subjects: PLEURA diseases; FEVER; MESOTHELIOMA

• Source: British Journal of Cancer; 6/16/2003, Vol. 88 Issue 12, p1839-1843, 5p

تفاصيل العنوان